Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics

KJ Harrington; RG Vile; A Melcher; J Chester; HS Pandha

doi:10.1016/j.cytogfr.2010.02.006

Back

Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics

Journal article

Peer reviewed

Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics

KJ Harrington, RG Vile, A Melcher, J Chester and HS Pandha

CYTOKINE & GROWTH FACTOR REVIEWS, Vol.21(2-3), pp.91-98

01/04/2010

DOI: https://doi.org/10.1016/j.cytogfr.2010.02.006

Abstract

Science & Technology

Life Sciences & Biomedicine

Biochemistry & Molecular Biology

Cell Biology

BIOCHEMISTRY & MOLECULAR BIOLOGY

CELL BIOLOGY

Oncolytic virus

Reovirus

Chemotherapy

Radiotherapy

Clinical trial

CARCINOEMBRYONIC ANTIGEN

MONOCLONAL-ANTIBODIES

ANTITUMOR EFFICACY

IMMUNE-RESPONSE

CYCLOSPORINE-A

CELL-LINES

CANCER

THERAPY

TUMORS

VIRUS

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000279425600003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

34 Record Views

74 Times Cited - Web of Science

See more details

Details

Title: Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics
Creators: KJ Harrington
RG Vile
A Melcher
J Chester
HS Pandha
Publication Details: CYTOKINE & GROWTH FACTOR REVIEWS, Vol.21(2-3), pp.91-98
Publisher: ELSEVIER SCI LTD
Date published: 01/04/2010
Date submitted: 17/05/2017
Identifiers: 99512937902346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics

Abstract

Files and links (1)

Metrics

Details

Usage Policy